Unforeseen changes in seasonality of pediatric respiratory illnesses during the first COVID‐19 pandemic year

• Published in: Pediatric pulmonology Vol. 57; no. 6; pp. 1425 - 1431
• Main Authors: Be'er, Moria, Amirav, Israel, Cahal, Michal, Rochman, Mika, Lior, Yotam, Rimon, Ayelet, Lavy, Roni G., Lavie, Moran
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.06.2022; John Wiley and Sons Inc
• Subjects: Asthma; bronchiolitis; children; COVID-19; Health services utilization; healthcare utilization; lockdown; Original; Pandemics; Pediatrics; pneumonia; Respiratory diseases; respiratory illness; Seasonal variations; COVID-19; healthcare utilization; pneumonia; children; respiratory illness; lockdown; asthma; bronchiolitis
• ISSN: 8755-6863; 1099-0496
• DOI: 10.1002/ppul.25896

Objectives To investigate whether the three nationwide coronavirus disease 2019 (COVID‐19) lockdowns imposed in Israel during the full first pandemic year altered the traditional seasonality of pediatric respiratory healthcare utilization. Methods Month by month pediatric emergency department (ED) visits and hospitalizations for respiratory diagnoses during the first full COVID‐19 year were compared to those recorded for the six consecutive years preceding the pandemic. Data were collected from the patients' electronic files by utilizing a data extraction platform (MDClone©). Results A significant decline of 40% in respiratory ED visits and 54%–73% in respiratory hospitalizations during the first COVID‐19 year compared with the pre‐COVID‐19 years were observed (p < 0.001 and p < 0.001, respectively). The rate of respiratory ED visits out of the total monthly visits, mostly for asthma, peaked during June 2020, compared with proceeding years (109 [5.9%] versus 88 [3.9%] visits; p < 0.001). This peak occurred 2 weeks after the lifting of the first lockdown, resembling the “back‐to‐school asthma” phenomenon of September. Conclusions This study demonstrates important changes in the seasonality of pediatric respiratory illnesses during the first COVID‐19 year, including a new “back‐from‐lockdown” asthma peak. These dramatic changes along with the recent resurgence of respiratory diseases may indicate the beginnings of altered seasonality in pediatric pulmonary pathologies as collateral damage of the pandemic.